You just read:

Champions Biotechnology Announces Master Service Agreement with Teva Pharmaceutical Industries, Ltd. for the Evaluation of a Novel Oncology Compound

News provided by

Champions Biotechnology, Inc.

Dec 06, 2010, 07:00 ET